Susceptibility to Eye Diseases in Relation to Age and Kidney Failure Among Taiwanese Adults

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2024 Feb 19

PMID 38374002

Authors

Shin-Lin Chiu

Oswald Ndi Nfor

Chiu-Liang Chen

Disline Manli Tantoh

Wen Yu Lu

Pei-Hsin Chen

Yung-Po Liaw

Affiliations

Soon will be listed here.

Abstract

Background: The kidney and eyes share common pathways and are thought to be closely connected. Chronic kidney disease and major eye diseases, such as cataract and glaucoma, are strongly associated with age. However, further investigation is needed to understand the joint impact of age and kidney diseases on eye diseases. In this study, we assessed the risk of eye diseases in relation to age and kidney failure in Taiwanese adults.

Methods: Our study included 127,561 cancer-free volunteers aged 30 to 70 years who participated in the Taiwan Biobank (TWB) project from 2008 to 2020. Information on the main exposures (kidney failure and age) and the outcome (eye diseases, including glaucoma, cataract, xerophthalmia, and retinal detachment) was collected through questionnaires.

Results: In general, kidney failure and older age were independently associated with a higher risk of eye, particularly cataract and retinal detachment: prevalence odds ratio (POR); 95% confidence interval (CI) = 2.480; 1.635-3.761 for cataract and 3.885; 1.968-7.666 for retinal detachment. A significant interaction between kidney failure and age on cataract was observed (p-value = 0.0002). Age-stratified analysis revealed a higher risk of cataract among patients with kidney failure aged below 50 (POR = 6.534; 95% CI = 2.493-17.124) and between 50 and 60 years (POR = 3.957; 95%CI = 1.986-7.881). Combining kidney failure and age (reference: no kidney failure and age < 50 years), kidney failure in all age groups was associated with a higher risk of cataract. The PORs; 95% CIs were 10.725; 4.227-27.211 for patients below 50 years, 28.487; 14.270-56.866 for those aged 50-60 years, and 43.183; 24.434-72.824 for those > 60 years. Combining cataract and age (reference: no cataract and age < 50 years), patients below 50 years had the highest risk of kidney failure (POR; 95% CI = 9.510; 3.722-24.297).

Conclusions: Our study suggests that age and kidney failure may jointly contribute to eye diseases, particularly cataract. The association between cataract and kidney failure could be bidirectional, especially in individuals below 50 years. This significant bidirectional relationship underscores the need for screening patients with cataract for kidney failure and vice versa, particularly in younger adults.

Citing Articles

Eye diseases: a global concern across age, race, and environment.

Takefuji Y Eye (Lond). 2024; 38(15):2849-2850.

PMID: 38862645 PMC: 11461890. DOI: 10.1038/s41433-024-03179-x.

References

Cohen L, Pasquale L . Clinical characteristics and current treatment of glaucoma. Cold Spring Harb Perspect Med. 2014; 4(6). PMC: 4031956. DOI: 10.1101/cshperspect.a017236. View

Cheng A, Pang C, Leung A, Chua J, Fan D, Lam D . The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000; 6(2):195-202. View

Huynh S, Kifley A, Strippoli G, Mitchell P . Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study. Ophthalmology. 2005; 112(2):293-300. DOI: 10.1016/j.ophtha.2004.09.014. View

Zetterberg M, Celojevic D . Gender and cataract--the role of estrogen. Curr Eye Res. 2014; 40(2):176-90. DOI: 10.3109/02713683.2014.898774. View

Kaesler N, Babler A, Floege J, Kramann R . Cardiac Remodeling in Chronic Kidney Disease. Toxins (Basel). 2020; 12(3). PMC: 7150902. DOI: 10.3390/toxins12030161. View

Nusinovici S, Sabanayagam C, Teo B, Wei Tan G, Wong T . Vision Impairment in CKD Patients: Epidemiology, Mechanisms, Differential Diagnoses, and Prevention. Am J Kidney Dis. 2019; 73(6):846-857. DOI: 10.1053/j.ajkd.2018.12.047. View

. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020; 9(2):e144-e160. PMC: 7820391. DOI: 10.1016/S2214-109X(20)30489-7. View

Wong C, Wong T, Cheng C, Sabanayagam C . Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2013; 85(6):1290-302. DOI: 10.1038/ki.2013.491. View

Cekic S, Zlatanovic G, Cvetkovic T, Petrovic B . Oxidative stress in cataractogenesis. Bosn J Basic Med Sci. 2010; 10(3):265-9. PMC: 5504506. DOI: 10.17305/bjbms.2010.2698. View

10.

Rowe S, Maclean C, Shekelle P . Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA. 2004; 291(12):1487-95. DOI: 10.1001/jama.291.12.1487. View

11.

Feng Y, Chen C, Chen T, Kuo P, Hsu Y, Yang H . Taiwan Biobank: A rich biomedical research database of the Taiwanese population. Cell Genom. 2023; 2(11):100197. PMC: 9903657. DOI: 10.1016/j.xgen.2022.100197. View

12.

Kooman J, Kotanko P, Schols A, Shiels P, Stenvinkel P . Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014; 10(12):732-42. DOI: 10.1038/nrneph.2014.185. View

13.

Trott M, Smith L, Veronese N, Pizzol D, Barnett Y, Gorely T . Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies. Eye (Lond). 2021; 36(2):369-378. PMC: 8807837. DOI: 10.1038/s41433-021-01684-x. View

14.

Wang T, Wu C, Hu C, Keller J, Lin H . Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study. Ophthalmic Epidemiol. 2012; 19(3):137-43. DOI: 10.3109/09286586.2012.680531. View

15.

Barnett L, Cummings B . Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective. Toxicol Sci. 2018; 164(2):379-390. DOI: 10.1093/toxsci/kfy159. View

16.

Klein B, Klein R, Lee K, Knudtson M, Tsai M . Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol. 2006; 141(1):116-22. DOI: 10.1016/j.ajo.2005.08.021. View

17.

Eknoyan G, Lameire N, Barsoum R, Eckardt K, Levin A, Levin N . The burden of kidney disease: improving global outcomes. Kidney Int. 2004; 66(4):1310-4. DOI: 10.1111/j.1523-1755.2004.00894.x. View

18.

Wong C, Lamoureux E, Cheng C, Cheung G, Tai E, Wong T . Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study. EBioMedicine. 2016; 5:193-7. PMC: 4816758. DOI: 10.1016/j.ebiom.2016.01.023. View

19.

Liu Y, Hung T, Lee Y, Huang M, Hsu C, Su Y . Association between Chronic Kidney Disease and Risk of Cataract: A Nationwide Retrospective Cohort Study. Am J Nephrol. 2017; 45(6):524-531. DOI: 10.1159/000475555. View

20.

Zhu Z, Liao H, Wang W, Scheetz J, Zhang J, He M . Visual Impairment and Major Eye Diseases in Chronic Kidney Disease: The National Health and Nutrition Examination Survey, 2005-2008. Am J Ophthalmol. 2020; 213:24-33. DOI: 10.1016/j.ajo.2020.01.002. View